Clinical and pathological determinants of abstinence rate in smoking cessation with varenicline

A. Antunes, J. Gomes, A. I. Loureiro, M. Guimarães, I. Pascoal (Vila Nova Gaia, Vila Real, Portugal)

Source: Annual Congress 2010 - Smoking cessation interventions
Session: Smoking cessation interventions
Session type: Thematic Poster Session
Number: 2584

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Antunes, J. Gomes, A. I. Loureiro, M. Guimarães, I. Pascoal (Vila Nova Gaia, Vila Real, Portugal). Clinical and pathological determinants of abstinence rate in smoking cessation with varenicline. Eur Respir J 2010; 36: Suppl. 54, 2584

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Causes of quitting treatment with varenicline in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009

Factors affecting the success of smoking cessation treatment in a smoking cessation clinic
Source: International Congress 2017 – Smoking cessation
Year: 2017

Abstinence rates and predictors of outcome for smoking cessation
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


Predictors of smoking cessation
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Factors associated with abstinence and effectiveness of a smoking cessation program
Source: Eur Respir J 2006; 28: Suppl. 50, 390s
Year: 2006

Zyban and smoking cessation: predictors of success
Source: Eur Respir J 2003; 22: Suppl. 45, 126s
Year: 2003

Evaluation of smoking cessation rate
Source: Eur Respir J 2003; 22: Suppl. 45, 125s
Year: 2003

Improvement of quit smoking rate by combining varenicline and nicotine replacement therapy
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Factors influencing dropout of a smoking cessation consultation in patients treated with varenicline
Source: Annual Congress 2012 - Act to change tobacco epidemics
Year: 2012

Relapse rates following different types of medication treatment through a smoking cessation program
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006


Effectiveness of varenicline treatment in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009


Smoking cessation according to nicotine dependence: experience of a smoking cessation program
Source: Virtual Congress 2020 – From tobacco control policy to smoking cessation
Year: 2020


The success rate of a smoking cessation programme in patients attempted to quit smoking
Source: Eur Respir J 2002; 20: Suppl. 38, 133s
Year: 2002

Evaluation of prolonged bupropion treatment as an aid in smoking cessation
Source: Eur Respir J 2002; 20: Suppl. 38, 611s
Year: 2002

Smoking habit, smoking cessation and relapse rates in patients with comorbid diseases
Source: Annual Congress 2010 - Smoking cessation interventions
Year: 2010

Factors associated with relapse in smoking cessation
Source: Annual Congress 2012 - Tobacco cessation
Year: 2012

Factors associated with smoking cessation in a smoking cessation unit
Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions
Year: 2011